Phenotypic Characterization and Comparison of Phe508del and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Knockout Rat Models of Cystic Fibrosis Generated by CRISPR/Cas9 Gene Editing

April 20, 2020 | Histopathology

No need to search at great lengths for current Histopath industry news as Lab.Equipment ensures you are updated wherever and whenever. This week’s curated article is fresh from The American Journal of Pathology:

Animal models of cystic fibrosis (CF) are essential for investigating disease mechanisms and trialling potential therapeutics. This study generated two CF rat models using clustered regularly interspaced short palindromic repeats (CRISPR)/ CRISPR associated protein 9 (Cas9) gene editing. One rat model carries the common human Phe508del (ΔF508) CF transmembrane conductance regulator (CFTR) mutation, whereas the second is a CFTR knockout model. Phenotype was characterized using a range of functional and histological assessments including nasal potential difference to measure electrophysiological function in the upper airways, RNAscope in situ hybridization and quantitative PCR to assess CFTR mRNA expression in the lungs, immunohistochemistry to localize CFTR protein in the airways, and histopathological assessments in a range of tissues.... More of this in  The American Journal of Pathology Blog.

If you are in the Histopathology industry and are in need of reliable Histopath equipment for your basic and advanced applications, then you are in the right place. Lab.Equipment presents an extensive selection of equipment for facilities analyzing and running histopath tests. Browse our highly-recommended Pathology lab equipment like: 

We offer equipment from recognized MFGs such as: 

Focusing on veterinary, forensics, microbiology applications? Rely on Lab.Equipment to help enhance your efficiency and productivity. Get accurate lab equipment for whatever application here.

Back To Top
We are fully compliant with the GDPR laws. We promise to safeguard your data and protect your privacy rights.